Wanbury Ltd

Wanbury is engaged in the business of pharmaceutical and related activities, including research.

  • Market Cap: 52.49 Cr.
  • Current Price: 20.15
  • 52 weeks High / Low 33.40 / 10.75
  • Book Value: -81.98
  • Stock P/E:
  • Dividend Yield: 0.00 %
  • ROCE: 25.47 %
  • ROE: %
  • Sales Growth (3Yrs): -2.37 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 10.00
Edit ratios
Pros:
Company has reduced debt.
Cons:
Company has low interest coverage ratio.
Promoter holding has decreased by -2.80% over last quarter
Contingent liabilities of Rs.533.30 Cr.
Promoters have pledged 76.76% of their holding.
Company's cost of borrowing seems high

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019
86 99 105 102 94 109 97
86 96 100 94 86 94 89
Operating Profit -0 3 5 7 9 15 8
OPM % -0% 3% 5% 7% 9% 14% 8%
Other Income 0 1 1 7 0 0 -0
Interest 6 6 6 22 7 8 7
Depreciation 3 3 2 2 2 2 2
Profit before tax -9 -4 -2 -10 -1 5 -2
Tax % 0% 0% 1% 1% 4% -0% 1%
Net Profit -9 -4 -2 -10 -1 5 -2
EPS in Rs -3.59 -1.79 0.00 -4.17 -0.35 2.12 -0.90
Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Sep 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
612 242 472 384 386 459 661 250 420 432 370 391 402
542 280 459 426 389 491 637 228 387 414 438 375 363
Operating Profit 70 -38 12 -42 -3 -32 25 21 33 19 -68 16 39
OPM % 11% -16% 3% -11% -1% -7% 4% 9% 8% 4% -18% 4% 10%
Other Income 19 62 56 14 21 5 -78 6 0 90 76 9 8
Interest 37 21 42 47 40 37 48 19 32 36 31 40 45
Depreciation 18 33 16 16 17 23 23 5 9 10 10 10 10
Profit before tax 34 -30 11 -91 -39 -87 -125 4 -7 62 -32 -25 -8
Tax % 8% -7% 21% 8% -0% -0% -2% 28% -0% 1% 1% 1%
Net Profit 32 -32 8 -84 -39 -87 -128 3 -7 62 -32 -25 -8
EPS in Rs 14.25 0.00 5.56 0.00 0.00 0.00 0.00 3.21 0.00 26.71 0.00 0.00 -3.30
Dividend Payout % 2% -0% 17% -0% -0% -0% -0% 0% -0% 0% -0% -0%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:4.91%
5 Years:%
3 Years:-2.37%
TTM:5.68%
Compounded Profit Growth
10 Years:2.15%
5 Years:%
3 Years:%
TTM:22.83%
Stock Price CAGR
10 Years:-12.70%
5 Years:-17.83%
3 Years:-23.38%
1 Year:-0.74%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:None%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Sep 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
15 15 15 15 17 17 20 20 20 23 24 24 24
Reserves 157 115 151 64 27 -65 -212 -214 -221 -176 -208 -233 -229
Borrowings 449 473 469 417 455 415 389 381 362 300 250 263 148
236 224 166 266 309 406 209 209 227 265 207 232 342
Total Liabilities 857 827 801 761 809 773 406 396 388 412 273 286 284
462 445 441 439 439 423 174 164 180 186 178 172 168
CWIP 18 19 22 14 17 25 13 19 14 10 10 9 11
Investments 1 39 1 1 1 1 0 0 0 0 0 0 0
376 323 339 308 352 324 219 213 193 216 84 105 105
Total Assets 857 827 801 761 809 773 406 396 388 412 273 286 284

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Sep 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
-100 72 42 137 9 87 68 40 43 43 32 30
-39 -62 -14 -10 -32 -21 -6 -5 -20 -13 -1 -3
131 4 -42 -129 24 -64 -71 -30 -28 -27 -33 -27
Net Cash Flow -7 15 -15 -2 2 3 -9 5 -5 3 -2 -0

Ratios Consolidated Figures in Rs. Crores / View Standalone

Sep 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Sep 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 8% -8% -1% -11% 4% 15% 64% -1% 25%
Debtor Days 106 237 112 92 107 67 57 144 65 71 29 41
Inventory Turnover 8.19 7.57 7.15 9.03 16.95 12.29 12.56 15.64 24.14